Purpose:To investigate the use of proton pump inhibitors (PPIs) and the risk of
pancreatic cancer.Methods:A nested case–control analysis was conducted. Patients with pancreas cancer
were matched with controls by propensity score. Univariate and multivariate
logistic regression models were used to determine whether PPIs use affected
the risk of pancreas cancer. Dose effect was analyzed based on the
cumulative defined daily dose (DDD), which was calculated using the total
supply of PPIs to individual patients in terms of days and quantity.Results:A total of 1087 patients with pancreas cancer were matched with 1087 control
patients from the database. The overall adjusted odds ratio (OR) of PPI use
associated with pancreas cancer was 1.69 (95% confidence interval [CI],
1.44-2.05). Dose analysis by cumulative DDD, based on all types of PPI
combined, revealed a lower adjusted OR of 0.92 (95% CI, 0.64-1.33) for those
on <30 cumulative DDD compared with those on ≥150 cumulative DDD, whose
adjusted OR was 2.19 (95% CI, 1.68-2.85). Compared with PPI nonusers, the
risks of pancreas cancer were: OR 0.89 (95% CI, 0.62-1.27) for patients
using PPI <30 days and 2.22 (95% CI, 1.68-2.94) for ≥150 days.Conclusions:Risk of pancreas cancer was associated with PPI use in patients with peptic
ulcer diseases or gastroesophageal reflux disease.
Communication is closely related to safe practice and patient outcomes. Given that most clinicians fall into routines when communicating with patients, it is important to address communication issues early. This study explores Taiwanese nursing students’ experiences of communication with patients with cancer and their families. Senior nursing students who had cared for cancer patients were recruited to participate in focus group interviews. These semi‐structured interviews were recorded and transcribed for content analysis. Among the 45 participants, about 36% of them never received any communication training. Up to 76% of the participants stated that their communication with cancer patients was difficult and caused them emotional stress. Subsequent data analysis revealed four themes: disengagement, reluctance, regression and transition. Students’ negative communication experiences were related to the patients’ terminally ill situation; the students’ lack of training, low self‐efficacy and power status, poor emotional regulation, and cultural considerations. The findings of this study provide a deeper understanding of nursing students’ communication experiences in oncology settings within the cultural context. Early and appropriate communication training is necessary to help students regulate their emotions and establish effective communication skills. Further studies are needed to examine the relationship among students’ emotional labour, communication skills and outcomes.
Background: The present study aimed to examine the odds of cholangiocarcinoma (CCA) in patients with proton pump inhibitors (PPIs) use.Methods: A nested case-control study design was employed using data obtained from Taiwan's National Health Insurance Research Database. In total, 2,293 patients with confirmed diagnosis of CCA were identified and served as the CCA group. The CCA patients were propensity score-matched with 2,293 subjects without CCA who served as the control group. The cumulative defined daily dose (DDD) of PPIs was calculated based on the total supply in days and quantity of individual PPIs. Univariable and multivariate logistic regression models were used to determine the odds of CCA, and calculated odds ratios (ORs) and 95% confidence intervals (CI) were used to assess PPIs use and odds of CCA.Results: The overall adjusted OR of PPIs use-associated CCA was 2.58 (95% CI 2.27, 2.93). The adjusted OR of CCA by cumulative DDD dose of PPIs and CCA was analyzed and revealed those odds of CCA are associated with all types of PPIs.Conclusions: There were odds of intrahepatic and extrahepatic CCA among PPIs users. All PPIs use was associated with odds of CCA. Analyses of larger numbers of cases are needed to confirm these findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.